Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimating defibrillation efficacy using combined upper limit of vulnerability and defibrillation testing

R A Malkin1, T C Pilkington, R E Ideker

  • 1University of Memphis, Department of Biomedical Engineering, Herff College of Engineering, TN 38152, USA. ramalkin@cc.memphis.edu

IEEE Transactions on Bio-Medical Engineering
|January 1, 1996
PubMed
Summary

Estimating defibrillation strength (DF) is crucial. A new method combines defibrillation testing with upper limit of vulnerability (ULV) testing, reducing patient risk and improving accuracy for determining optimal defibrillation stimulus levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Mechanisms of electrical defibrillation].

Herzschrittmachertherapie & Elektrophysiologie·2009
Same author

[Not Available].

Herzschrittmachertherapie & Elektrophysiologie·2009
Same author

Epicardial wavefronts arise from widely distributed transient sources during ventricular fibrillation in the isolated swine heart.

New journal of physics·2008
Same author

[Transvenous parasympathetic nerve stimulation in the chronic myocardial infarction phase].

Zeitschrift fur Kardiologie·2004
Same author

Frequency dependence of the cardiac threshold to alternating current between 10 Hz and 160 Hz.

Medical & biological engineering & computing·2003
Same author

The relationship of defibrillation and stimulation: design implications for the optimum defibrillation waveform.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2003

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Statistical Modeling

Background:

  • Estimating defibrillation stimulus strength is vital for clinical and laboratory settings.
  • Current defibrillation testing (DF testing) is time-consuming and carries patient risks.
  • Existing methods necessitate repeated induction of ventricular fibrillation (VF).

Purpose of the Study:

  • To present a novel, more efficient, and safer method for estimating defibrillation efficacy.
  • To introduce a Bayesian statistical model integrating upper limit of vulnerability (ULV) testing with DF testing.
  • To design minimum root-mean-square (rms) error protocols for estimating DF95, the stimulus strength for 95% defibrillation success.

Main Methods:

  • Developed a Bayesian statistical model combining ULV and DF testing data.

Related Experiment Videos

  • Applied the model to design protocols for estimating DF95 with minimized rms error.
  • Validated the model through human simulations and direct comparison with porcine laboratory results.
  • Main Results:

    • A single VF episode using combined ULV/DF testing achieved a lower rms error (23%) than two DF testing episodes alone (25%) in human simulations.
    • Simulated results for a second example showed less than 1.0% average difference compared to laboratory findings in pigs.
    • ULV testing provides data well-correlated with defibrillation efficacy, enhancing the combined testing model.

    Conclusions:

    • The combined ULV/DF testing scheme offers a powerful and concise approach to estimate defibrillation strength.
    • This novel method is more efficient and potentially safer than traditional DF testing alone.
    • The Bayesian model accurately predicts defibrillation efficacy, with strong correlation between simulated and empirical data.